LO News 59.14 08/28/2014 05:22:18 Lorillard Inc (LO)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lorillard Inc (LO) 59.14 $LO

5 Things Philip Morris International's Management Wants You to Know
Dan Caplinger, The Motley Fool - Motley Fool - Wed Aug 27, 4:12PM CDT
Source: Philip Morris International. For tobacco-industry investors, Philip Morris International has long held the promise of worldwide growth in cigarette demand as a larger consumer class in emerging-market nations gains enough disposable...

Uptrend Call Working As Lorillard Stock Rises 13.6% (LO)
Comtex SmarTrend(R) - Wed Aug 27, 9:24AM CDT
SmarTrend identified an Uptrend for Lorillard (NYSE:LO) on March 3rd, 2014 at $51.92. In approximately 6 months, Lorillard has returned 13.65% as of today's recent price of $59.00.

Watch for Shares of Lorillard (LO) to Approach Support at $58.80
Comtex SmarTrend(R) - Wed Aug 27, 9:01AM CDT
Shares of Lorillard (NYSE:LO) have bearishly opened below the pivot of $59.93 today and have reached the first support level of $59.24. Should the shares continue to fall, the support pivots of $58.80 and $57.67 will be of interest.

Is It Time to Buy Altria Group, Inc. Stock?
Dan Caplinger, The Motley Fool - Motley Fool - Tue Aug 26, 6:00PM CDT
Source: Wikimedia Commons. For decades, Altria Group has been a leader in the tobacco industry, giving investors huge total returns both from its always-impressive dividend yield and long-term share-price appreciation. Even as the regulatory...

Look for Shares of Lorillard to Potentially Rebound after Yesterday's 1.22% Sell Off
Comtex SmarTrend(R) - Tue Aug 26, 3:45PM CDT
Lorillard (NYSE:LO) traded in a range yesterday that spanned from a low of $59.50 to a high of $60.63. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $60.21 on volume of 4.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Multiple Agreement Executions, New Lab Facility, Dividend Declaration, Market Activity, and Upcoming Events - Research Reports on WPX, Johnson Controls, Lorillard, Itau Unibanco and KeyCorp
PR Newswire - Tue Aug 26, 8:00AM CDT
Today, Analysts Review released its research reports regarding WPX Energy, Inc. (NYSE: WPX), Johnson Controls Inc. (NYSE: JCI), Lorillard, Inc. (NYSE: LO), Itau Unibanco Holding S.A. (NYSE: ITUB) and KeyCorp (NYSE: KEY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5980-100free.

'Fast Money' Recap: Next Stop, S&P 2,100?
at The Street - Tue Aug 26, 4:00AM CDT
The trading panel looked at banks and the top buy and sell candidates for right now.

Altria (MO) Rewards Shareholders with 8.3% Dividend Hike - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 5:25PM CDT
The board of cigarette maker Altria Group, Inc. (MO) has announced a quarterly dividend hike of 8.3% to 52 cents per share.

Shares of LO Up 17.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Aug 19, 5:05PM CDT
SmarTrend identified an Uptrend for Lorillard (NYSE:LO) on March 3rd, 2014 at $51.92. In approximately 6 months, Lorillard has returned 17.17% as of today's recent price of $60.83.

Is This the Real Reason Lorillard Is Willing to Sell blu eCigs?
Rich Duprey, The Motley Fool - Motley Fool - Tue Aug 19, 5:03PM CDT
Since the rumors of a merger between Reynolds-American  and Lorillard had been swirling for months it wasn't a real surprise when a deal was finally announced last month, but what did raise some eyebrows was the decision to sell the latter's...

3 Reasons Lorillard Inc.'s Stock Could Fall
Rich Duprey, The Motley Fool - Motley Fool - Tue Aug 19, 10:43AM CDT
Shares of tobacco giant Lorillard are up nearly 50% over the past year, with much of the gains occurring earlier this year, when rumors of a possible merger started making the rounds. Hearsay became fact last month, however, when Reynolds...

3 Top Dividend Stocks of 2014
Selena Maranjian, The Motley Fool - Motley Fool - Mon Aug 18, 5:30PM CDT
Photo: Steve Depolo . It's always smart to seek solid dividend-paying stocks for your portfolio, as they tend to be reliable performers, and their payouts can bolster a portfolio during market downturns. When I decided to look into the top...

How Will Lorillard (LO) Stock React After Zippo Wins German Preliminary Injunction Over Blu E-Cig?
at The Street - Mon Aug 18, 2:32PM CDT
Lorillard (LO) subsidiary Cygnet UK Trading was ordered by a German court to stop selling the popular blu e-cigarettes in that country.

Is It Time to Buy Philip Morris International Stock?
Dan Caplinger, The Motley Fool - Motley Fool - Mon Aug 18, 9:07AM CDT
Source: Philip Morris International. The tobacco industry has been a very profitable space for investors over the long run, and shareholders in Philip Morris International have been quite pleased with the international tobacco giant's results...

Lorillard Earnings Review: 19 Days after Announcement Shares Down 1.1% (LO)
Comtex SmarTrend(R) - Mon Aug 18, 7:03AM CDT
When Lorillard (NYSE:LO) reported earnings two weeks ago on July 30th, 2014, analysts, on average, expected the company to report earnings of $0.88 on sales of $1.3 billion. The company actually reported EPS of $0.84 on sales of $1.3 billion, missing EPS estimates by $0.04 and missing revenue estimates by $45.4 million. Shares of Lorillard have slipped from $61.21 to $60.55, representing a loss of 1.1%, since the company reported earnings 19 days ago.

Lorillard declares dividend of USD0.615 per share for quarter
M2 - Mon Aug 18, 4:56AM CDT
Lorillard Inc (NYSE:LO), a US-based tobacco company, on Friday released a quarterly common stock dividend of USD0.615 per share.

Did CVS Burn Itself by Banning Tobacco Sales?
Rich Duprey, The Motley Fool - Motley Fool - Sun Aug 17, 12:01PM CDT
CVS Caremark warned earlier this year that its decision to ban tobacco sales from all of its stores would come with costs, but investors may not have realized just how widespread they would be. CVS Caremark will stub out all tobacco sales at...

Lorillard, Inc. Announces Quarterly Dividend on Common Stock
PR Newswire - Fri Aug 15, 7:00AM CDT
Lorillard, Inc. (NYSE: LO), the third largest tobacco company in the United States, announced today the declaration of a quarterly dividend on its common stock in the amount of $0.615 per share. The dividend is payable on September 10, 2014 to stockholders of record as of September 1, 2014.

Technical Updates, Rig Count Report, Product Recall, and Earnings Releases - Research Reports on Apache, Baker Hughes, Altria, Tyson Foods and Lorillard
PR Newswire - Wed Aug 13, 7:50AM CDT
Today, Analysts Review released its research reports regarding Apache Corp. (NYSE: APA), Baker Hughes Incorporated (NYSE: BHI), Altria Group Inc. (NYSE: MO), Tyson Foods, Inc. (NYSE: TSN) and Lorillard Inc. (NYSE: LO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5693-100free.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 111

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 78

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 170

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading
Loyalty Programs Cut $1500 Annually for Consumers

Updated Category News Views 103

Loyalty Programs: An Essential Tool for Households In a world where every dollar counts, retail loyalty programs have become more than just a marketing strategy—they're lifelines for American households scraping through each month. According to fresh research by the Retail Industry Leaders Association (RILA) and conducted by market research leader Circana, these...

Continue Reading
Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 55

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 161

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
AI Alliance Rethinks Health Plan Engagement

Updated Category News Views 139

Building Bridges in Healthcare Ever seen healthcare stuck in its own muck with disconnected gears attempting to move the same machine? Well, that's precisely the mountain healthplans.ai and URAWARRIOR aim to climb down from. Founders Rachel Spilo and Dr. Bershan Shaw are gearing up to shake hands in their no-nonsense, real-world vow to sync member engagement with the...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 89

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading
Quantum X and Everest Cloud Partner in South Asia Push

Updated Category News Views 61

An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...

Continue Reading
Salvation Army’s Angel Tree: 2026 Holiday Cheer Drive

Updated Category News Views 120

Kickstarting Holiday Generosity: The Angel Tree Program Man, there's something heartwarming about a Christmas that shines bright for everyone. The Salvation Army's Angel Tree program is back for another season, rolling up with a mission to spark joy across the country. For over 45 years now, this initiative's been the answer to many Christmas wish lists, especially for...

Continue Reading

Top 5 Most Recently Viewed Articles

Gap Inc. Sees Minor Sales Growth Amid Market Challenges

Updated Category News Views 254

Gap Inc. Experiences Modest Growth Gap Inc. demonstrated resilience in a challenging market, achieving a 1% increase in net sales compared to the previous year. The comparable sales rose by 3%, reflecting the brand's enhancement strategies. Brand Performance Highlight Each of Gap Inc.'s four major brands—Old Navy, Gap, Banana Republic, and Athleta—gained market share,...

Continue Reading
Innovative Lock Design Enhances Security for Commercial Trailers

Updated Category News Views 761

The SMART LOC: A Game-Changer for Trucking Security In a world where cargo theft is a persistent challenge, the development of an innovative solution is essential. Enter the SMART LOC, a new locking mechanism designed specifically for commercial trailers. This invention aims to significantly enhance security for trucking professionals, ultimately providing much-needed...

Continue Reading
GXO Logistics Prepares for First Quarter Earnings Call Soon

Updated Category News Views 198

GXO Logistics Set for First Quarter Earnings Presentation GXO Logistics, Inc. (NYSE: GXO) is preparing for its first quarter earnings conference call, which is scheduled for May 8, 2025, at 8:30 a.m. Eastern Time. During this call, the company will share its financial results and key insights into its business performance. Interested participants are encouraged to join in...

Continue Reading
Legal Action Against Everus Construction Group for Investors

Updated Category News Views 132

Overview of Legal Proceedings Against Everus Construction Group Everus Construction Group, Inc. (NYSE: ECG) is currently facing significant legal challenges as a result of alleged securities law violations. The situation has prompted attention from shareholders and investors alike. The Gross Law Firm has taken the initiative to notify shareholders regarding this serious...

Continue Reading
Nxera Pharma and Cancer Research UK Collaborate to Combat Cancer

Updated Category News Views 121

Nxera Pharma Joins Forces with Cancer Research UK for Innovative Trials HTL0039732, a promising oral EP4 antagonist developed by Nxera, shows potential in tackling various types of cancer, especially when paired with leading immunotherapies. Currently, this drug is making progress through its Phase 1/2a clinical trials, highlighting its potential effectiveness across a...

Continue Reading